Daré Bioscience, Inc. (DARE)
USD 3.18
(-0.31%)
USD 3.18
(-0.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.8 Million | 10 Million | - | - | - | - |
| Cost of Revenue | 38.36 Thousand | 47.61 Thousand | 26.41 Thousand | 43.22 Thousand | 11.13 Thousand | 2440.00 |
| Gross Profit | 2.76 Million | 9.95 Million | -26.41 Thousand | -43.22 Thousand | -11.13 Thousand | -2440.00 |
| Operating Expenses | 33.6 Million | 41.38 Million | 39.06 Million | 27.4 Million | 14.34 Million | 11.69 Million |
| Selling, General and Administrative Expenses | 12.07 Million | 11.24 Million | 8.45 Million | 6.63 Million | 5.79 Million | 5.28 Million |
| Research and Development Expenses | 21.53 Million | 30.04 Million | 30.61 Million | 20.76 Million | 8.54 Million | 6.41 Million |
| Other Expenses | - | 100 Thousand | 2520.00 | 1514.00 | 81.05 Thousand | 143.49 Thousand |
| Cost and Expenses | 33.64 Million | 41.38 Million | 39.06 Million | 27.4 Million | 14.34 Million | 11.69 Million |
| Operating Income | -30.83 Million | -31.38 Million | -39.06 Million | -27.4 Million | -14.34 Million | -16.88 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -437.75 Million | -369.88 Thousand | -163.07 Thousand | -160.72 Thousand | 10.23 Million |
| Earnings before Tax | -30.16 Million | -30.94 Million | -38.69 Million | -27.4 Million | -14.26 Million | -16.73 Million |
| Net Income | -30.16 Million | -30.94 Million | -38.32 Million | -27.4 Million | -14.26 Million | -26.97 Million |
| Earnings Per Share Basic | -4.15 | -4.39 | -7.52 | -10.93 | -10.99 | -30.16 |
| Earnings Per Share Diluted | -4.15 | -4.39 | -7.52 | -10.93 | -10.99 | -30.16 |
| Weighted Average Shares Outstanding | 7.27 Million | 7.04 Million | 5.09 Million | 2.5 Million | 1.29 Million | 894.36 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 7.27 Million | 7.04 Million | 5.09 Million | 2.5 Million | 1.29 Million | 894.36 Thousand |
| Gross Margin | 0.99 | 1.00 | - | - | - | - |
| EBIT Margin | -10.93 | -3.14 | - | - | - | - |
| Profit Margin | -10.74 | -3.09 | - | - | - | - |
| EBITDA | -30.7 Million | -31.36 Million | -39.04 Million | -27.35 Million | -14.33 Million | -11.69 Million |
| Earnings Before Tax Margin | -10.98 | -3.14 | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 22.43 Thousand | 9302.00 | 2.8 Million | 1.8 Million | 1 Million | - |
| Cost of Revenue | 15.43 Thousand | 10.77 Thousand | 38.36 Thousand | 9980.00 | 9260.00 | 9615.00 |
| Gross Profit | 7001.00 | -1476.00 | 2.76 Million | 1.79 Million | 990.74 Thousand | -9615.00 |
| Operating Expenses | 7.34 Million | 5.98 Million | 33.6 Million | 6.94 Million | 9.39 Million | 8.98 Million |
| Selling, General and Administrative Expenses | 2.43 Million | 2.65 Million | - | 3.14 Million | 2.69 Million | 2.94 Million |
| Research and Development Expenses | 4.9 Million | 3.32 Million | - | 3.79 Million | 6.67 Million | 6.04 Million |
| Other Expenses | 20.27 Million | -732.88 Thousand | 778.48 Thousand | 113.89 Thousand | 25 Thousand | 227.12 Thousand |
| Cost and Expenses | 7.35 Million | 5.99 Million | 33.64 Million | 6.95 Million | 9.39 Million | 8.98 Million |
| Operating Income | -7.33 Million | -5.98 Million | -30.83 Million | -5.14 Million | -8.39 Million | -8.98 Million |
| Interest Expense | - | 7674.00 | - | - | - | - |
| Income Tax Expense | 3.00 | 2.00 | -3.00 | -33.83 Thousand | -9260.00 | -112.47 Thousand |
| Earnings before Tax | 12.91 Million | -6.75 Million | -30.16 Million | -5.05 Million | -8.29 Million | -8.76 Million |
| Net Income | 12.91 Million | -6.75 Million | -30.16 Million | -5.05 Million | -8.29 Million | -8.76 Million |
| Earnings Per Share Basic | 1.53 | -0.81 | - | -0.69 | -1.09 | -1.22 |
| Earnings Per Share Diluted | 1.52 | -0.81 | - | -0.69 | -1.09 | -1.22 |
| Weighted Average Shares Outstanding | 8.41 Million | 8.37 Million | 7.27 Million | 7.29 Million | 7.58 Million | 7.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 8.47 Million | 8.37 Million | 7.27 Million | 7.29 Million | 7.58 Million | 7.2 Million |
| Gross Margin | 0.31 | -0.16 | 0.99 | 0.99 | 0.99 | - |
| EBIT Margin | -326.19 | -642.77 | - | -2.84 | -8.40 | - |
| Profit Margin | 575.39 | -726.23 | -10.74 | -2.80 | -8.30 | - |
| EBITDA | -7.31 Million | -5.97 Million | - | -5.13 Million | -8.39 Million | -8.97 Million |
| Earnings Before Tax Margin | -326.88 | -643.93 | -10.98 | -2.85 | -8.40 | - |
CLPHF
SIEGY
BBXIA
FSGB
EMNSF
0ZNF